NCM

Nantahala Capital Management Portfolio holdings

AUM $1.62B
1-Year Est. Return 64.72%
This Quarter Est. Return
1 Year Est. Return
+64.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.62B
AUM Growth
+$206M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
167
New
Increased
Reduced
Closed

Top Buys

1
+$19.3M
2
+$17.2M
3
+$14.8M
4
GERN icon
Geron
GERN
+$12.4M
5
LBRX
LB Pharmaceuticals
LBRX
+$10.7M

Top Sells

1
+$78.6M
2
+$61M
3
+$27.2M
4
NKTR icon
Nektar Therapeutics
NKTR
+$16.6M
5
THRD
Third Harmonic Bio
THRD
+$16M

Sector Composition

1 Healthcare 69.32%
2 Consumer Discretionary 12.89%
3 Financials 5.23%
4 Communication Services 4.07%
5 Industrials 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHX icon
76
DHI Group
DHX
$80.6M
$6.6M 0.23%
2,374,027
CMCO icon
77
Columbus McKinnon
CMCO
$488M
$6.45M 0.22%
450,000
+246,372
VMD icon
78
Viemed Healthcare
VMD
$265M
$6.33M 0.22%
932,445
STKS icon
79
The ONE Group
STKS
$57.5M
$6.28M 0.22%
2,121,084
MLYS icon
80
Mineralys Therapeutics
MLYS
$2.91B
$6.02M 0.21%
158,713
-195,269
DXLG icon
81
Destination XL Group
DXLG
$59.3M
$5.9M 0.2%
4,505,000
+1,928,226
IRD
82
Opus Genetics
IRD
$165M
$5.52M 0.19%
3,345,923
AKBA icon
83
Akebia Therapeutics
AKBA
$419M
$5.46M 0.19%
2,000,000
GAIA icon
84
Gaia
GAIA
$88.2M
$5.41M 0.19%
914,618
SLN
85
Silence Therapeutics
SLN
$293M
$5.41M 0.19%
1,042,427
NNBR icon
86
NN Inc
NNBR
$59.7M
$5.03M 0.17%
2,441,416
QNCX icon
87
Quince Therapeutics
QNCX
$215M
$5.01M 0.17%
3,073,729
+545,427
SCPH
88
DELISTED
scPharmaceuticals
SCPH
$4.88M 0.17%
861,277
-134,161
KOD icon
89
Kodiak Sciences
KOD
$1.33B
$4.76M 0.17%
290,884
-300,000
HAIN icon
90
Hain Celestial
HAIN
$93.3M
$4.74M 0.16%
3,000,000
CGON icon
91
CG Oncology
CGON
$3.37B
$4.41M 0.15%
+109,449
BRCC icon
92
BRC Inc
BRCC
$142M
$4.1M 0.14%
+2,630,517
UNCY icon
93
Unicycive Therapeutics
UNCY
$140M
$4.09M 0.14%
939,202
AGIO icon
94
Agios Pharmaceuticals
AGIO
$1.57B
$4.01M 0.14%
+100,000
RYAM icon
95
Rayonier Advanced Materials
RYAM
$417M
$3.69M 0.13%
+510,510
IKT icon
96
Inhibikase Therapeutics
IKT
$177M
$3.55M 0.12%
2,190,000
GRCE
97
Grace Therapeutics
GRCE
$53.7M
$3.51M 0.12%
1,178,203
AQST icon
98
Aquestive Therapeutics
AQST
$744M
$3.35M 0.12%
+600,000
TLPH icon
99
Talphera
TLPH
$57.3M
$3.12M 0.11%
3,492,519
+1,500,000
NPCE icon
100
Neuropace
NPCE
$542M
$3.04M 0.11%
295,089
2 3
4
5 6